Matrixyl vs SNAP-8 / Argireline — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Matrixyl is the trade name for Palmitoyl Pentapeptide-4 (Pal-KTTKS), developed by Sederma (now Croda). It is derived from a procollagen type I C-terminal propeptide fragment and uses palmitoylation to cross the skin lipid barrier and reach dermal fibroblasts....
Calculate Matrixyl dose →SNAP-8 and Argireline are related cosmetic peptides that reduce wrinkle depth by partially inhibiting the SNARE complex involved in neurotransmitter vesicle release at the neuromuscular junction. Argireline (Acetyl Hexapeptide-3) is a 6-amino acid fragment; SNAP-8 (Acetyl Octapep...
Calculate SNAP-8 / Argireline dose →| Parameter | Matrixyl | SNAP-8 / Argireline |
|---|---|---|
| Category | Skin & Cosmetic | Skin & Cosmetic |
| Research | Widely Used (Cosmetic) | Widely Used (Cosmetic) |
| Half-Life | - | - |
| Typical Dose | 3–5% in formulation | 5–10% in formulation |
| Frequency | Twice daily | Twice daily |
| Route | Topical | Topical |
| FDA Status | Not Approved (Cosmetic) | Not Approved (Cosmetic) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.